- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06173193
Effects of Multicomponent Exercise on Subchondral Bone and Cartilage in Postmenopausal Women With Knee Osteoarthritis (LuRu2)
Effects of a Multicomponent Exercise Regimen on Subchondral Bone, Cartilage, and Inflammation Markers in Postmenopausal Women With Knee Osteoarthritis: A Randomized Controlled Study
Today, osteoarthritis (OA) is considered a whole-organ disease that is amenable to prevention and treatment in the early stages. Information on the articular cartilage and subchondral bone responses to exercise may help to develop safe and feasible exercise programs which can potentially improve cartilage and bone properties. Therefore, the goal of this study is to produce the knowledge needed to understand what effects multicomponent exercise regimen have on subchondral bone and articular cartilage of the knee joint in postmenopausal women with knee OA.
Participants will be randomized into either:
- Intervention group, which conducts multicomponent exercise regimen including alternating step-aerobic and resistance training.
- Reference group, which represents the standard rehabilitative management for knee OA patients with home exercises.
Researchers will compare intervention and reference groups to see if subchondral bone morphology and properties and cartilage biochemical alterations differ between the groups at the end of the 8-month intervention and 12-month follow-up period.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is an 8-month, randomized controlled intervention study with 12-month follow-up in volunteer postmenopausal (55-75-year-old) women with mild radiographic knee OA according to the Kellgren-Lawrence classification (grade 1-2). The participants will be randomly assigned into the subgroups. The study will be conducted in two phases.
8-month multicomponent exercise regimen will be carried out gradually and progressively three times a week by experienced and recently trained exercise instructors. The instructors will keep an attendance and an adverse event record for each of the intervention group's participants. The home exercises carried out three times a week by the reference group represent the standard rehabilitative management for knee OA patients.
In addition to the above-mentioned treatments, all participants will receive instructions to use paracetamol on an as-needed basis. Participants will be called to end-point measurements at 8 months after baseline and follow-up measurements at 20 months after baseline.
The overall goal of this study is to produce the knowledge needed to understand what effects multicomponent exercise regimen have on subchondral bone and articular cartilage of the knee joint in postmenopausal women with knee OA. In addition, the aim is to develop means to improve functional competence as well as to prevent physical disability among women suffering from knee OA. Specifically, the objectives are to investigate the effects of joint loading exercise regimen on knee joint subchondral bone morphology and properties, and cartilage biochemical alterations and their 12 month maintenance in women with knee OA. Also, training effects on molecular biomarkers related to OA and inflammation, bone traits, physical function, performance, body composition, and clinically important symptoms will be examined.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jyväskylä, Finland, 40014
- University of Jyväskylä
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- voluntary women 55-75 years of age.
- no history of any illness for which exercise is contraindicated or that would limit participation in the exercise program.
- knee pain during the last 12 months.
- willingness and voluntarily signed informed consent to undergo testing and intervention procedures with all of its aspects.
- weight-bearing knee x-rays show radiographic Kellgren-Lawrence grade 1-2 OA in one or both tibiofemoral joints.
Exclusion Criteria:
- body-mass index over 35 kg/m2.
- knee instability or trauma that would jeopardize the training.
- inflammatory joint disease.
- intra-articular steroid injections in the preceding 12 months in the knee.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: multicomponent exercise group
8 months of multicomponent exercise (3 sessions/week).
|
A multicomponent exercise regimen applied is comprised of the step-aerobic and resistance training programs alternating every two weeks. The trainees participate in supervised training sessions 3 times a week for 8 months. Each session will include a 10-minutes warm-up, 30-minutes of effective training part and a 10-minutes period for cooling down. Step-aerobic: The program includes accelerating and decelerating through forwards and sideways movements with stops and turns to music. The degree of difficulty of movements and steps as well as training intensity will be gradually increased by increasing the height of the step benches. Resistance training: The participants will undergo a progressive resistance training program. Resistance training will emphasize training of following muscle groups: Quadriceps and hamstrings, hip abductors, adductors and extensors, and calf muscles. In addition to lower limb exercises, trunk and upper body exercises will be applied at intervals. |
|
Active Comparator: Reference group
8 months of standard rehabilitative care based home exercises.
|
The treatments that will be provided to the members of a reference group represent the standard rehabilitative management for knee OA patients.
The home exercises focus on functional exercises maintaining lower extremity flexibility and muscle function.
The home exercises are instructed to be carried out three times a week, each work-out lasting 30 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tibiofemoral articular cartilage's glycosaminoglycan content
Time Frame: Baseline, 8 months, 20 months
|
Assessed by quantitative Magnetic Resonance Imaging (qMRI) techniques at 3Tesla MR-system.
Rotating frame of reference contrast adiabatic T1rho (ms) will be measured.
|
Baseline, 8 months, 20 months
|
|
Tibiofemoral articular cartilage's collagen content and orientation
Time Frame: Baseline, 8 months, 20 months
|
T2 maps (ms) will be assessed by qMRI techniques at 3Tesla MR-system.
In addition, some clinical MRI series will be conducted.
|
Baseline, 8 months, 20 months
|
|
Tibiofemoral articular cartilage thickness (mm)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by 3D-texture analysis.
|
Baseline, 8 months, 20 months
|
|
Tibiofemoral articular cartilage volume (mm^3)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by 3D-texture analysis.
|
Baseline, 8 months, 20 months
|
|
Tibiofemoral subchondral bone mineral density (g/cm^3)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by high-resolution cone beam computed tomography (CBCT).
|
Baseline, 8 months, 20 months
|
|
Tibiofemoral subchondral bone mineral content (g)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by high-resolution CBCT.
|
Baseline, 8 months, 20 months
|
|
Tibiofemoral joint space narrowing (mm)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by high-resolution CBCT.
|
Baseline, 8 months, 20 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone mineral content (BMC, g) of the femoral neck
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Dual-energy X-ray absorptiometry (DXA).
|
Baseline, 8 months, 20 months
|
|
Areal bone mineral density (aBMD, g/cm^2) of the femoral neck
Time Frame: Baseline, 8 months, 20 months
|
Assessed by DXA.
|
Baseline, 8 months, 20 months
|
|
Cortical thickness (mm) of the femoral neck
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Advanced Hip Analysis software.
|
Baseline, 8 months, 20 months
|
|
Femoral neck width (mm)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Advanced Hip Analysis software.
|
Baseline, 8 months, 20 months
|
|
Cross-sectional area (cm^2) of the femoral neck
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Advanced Hip Analysis software.
|
Baseline, 8 months, 20 months
|
|
Cross-sectional moment of inertia (cm^4) of the femoral neck
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Advanced Hip Analysis software.
|
Baseline, 8 months, 20 months
|
|
Section modulus (cm^3) of the femoral neck
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Advanced Hip Analysis software.
|
Baseline, 8 months, 20 months
|
|
Total body fat percentage (%)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by DXA.
|
Baseline, 8 months, 20 months
|
|
Fat Free Mass Index (FFMI, kg/m^2)
Time Frame: Baseline, 8 months, 20 months
|
Assessed by DXA.
|
Baseline, 8 months, 20 months
|
|
Clinically important OA-symptoms and physical function
Time Frame: Baseline, 8 months, 20 months
|
Assessed by Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire (Score 0-100).
Higher scores represent better outcomes.
|
Baseline, 8 months, 20 months
|
|
Health-related quality of life
Time Frame: Baseline, 8 months, 20 months
|
Assessed by RAND 36-Item Health Survey questionnaire (Scores 0-100 on different domains).
Higher scores represent a more favorable health state.
|
Baseline, 8 months, 20 months
|
|
Work disablement
Time Frame: Baseline, 8 months, 20 months
|
Assessed by short form of Örebro musculoskeletal pain screening questionnaire (Score 1-100).
Higher scores estimate increased risk for future work disability.
|
Baseline, 8 months, 20 months
|
|
Self-rated physical activity
Time Frame: IPAQ: Baseline, 8 months, 20 months. Physical activity diary: through the 8-month study intervention in the control group
|
Assessed by International Physical Activity Questionnaire (IPAQ, Metabolic equivalent task (MET) -minutes).
Also, physical activity diary (MET-minutes) will be filled by the control group through the 8-month study intervention.
|
IPAQ: Baseline, 8 months, 20 months. Physical activity diary: through the 8-month study intervention in the control group
|
|
Objective daily physical activity
Time Frame: See above
|
Assessed by a tri-axial accelerometer (minutes & MET-hours), worn 24 hours a day.
A tri-axial accelerometer will be used through the 8-month study intervention in the intervention group and periods of 7 consecutive days every two months during the 8-month study intervention in the control group.
During the 12-month follow-up, all the participants will be measured every four months for seven consecutive days.
|
See above
|
|
Quantity of painkillers consumed
Time Frame: Through the 8-month study intervention
|
Assessed by diary.
|
Through the 8-month study intervention
|
|
Systemic inflammation markers
Time Frame: Baseline, 8 months, 20 months
|
High sensitivity C-reactive protein and serum cytokines including interleukin-6 and tumor-necrosis factor alpha will be assessed from blood.
|
Baseline, 8 months, 20 months
|
|
Metabolic profile
Time Frame: Baseline, 8 months, 20 months
|
Circulating metabolomes including resistin, leptin, adiponectin, lipids, lipoproteins, and metabolites will be assessed from blood.
|
Baseline, 8 months, 20 months
|
|
Cardiorespiratory fitness
Time Frame: Baseline, 8 months, 20 months
|
Assessed by UKK 2km walk test (minutes and seconds).
|
Baseline, 8 months, 20 months
|
|
Knee extension and flexion maximal isometric muscle strength
Time Frame: Baseline, 8 months, 20 months
|
Assessed by an adjustable dynamometer chair (Newtons).
|
Baseline, 8 months, 20 months
|
|
Static balance
Time Frame: Baseline, 8 months, 20 months
|
Assessed by a single leg stance test (seconds).
|
Baseline, 8 months, 20 months
|
|
30 second chair-stand test (seconds)
Time Frame: Baseline, 8 months, 20 months
|
Baseline, 8 months, 20 months
|
|
|
Timed up and go (TUG) (seconds)
Time Frame: Baseline, 8 months, 20 months
|
Baseline, 8 months, 20 months
|
|
|
40m Fast-paced walk test (seconds)
Time Frame: Baseline, 8 months, 20 months
|
Baseline, 8 months, 20 months
|
|
|
Stair climb test (seconds)
Time Frame: Baseline, 8 months, 20 months
|
Baseline, 8 months, 20 months
|
|
|
Walking biomechanics
Time Frame: Baseline, 8 months, 20 months
|
Lower body's segmental acceleration (m/s^2) in 40m Fast-paced walk test, Stair climb test, and 2-minute walk at the subject's preferred pace will be assessed by Inertial Measurement Unit (IMU).
|
Baseline, 8 months, 20 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ari Heinonen, Prof., emeritus, University of Jyväskylä
Publications and helpful links
General Publications
- Dobson F, Hinman RS, Roos EM, Abbott JH, Stratford P, Davis AM, Buchbinder R, Snyder-Mackler L, Henrotin Y, Thumboo J, Hansen P, Bennell KL. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthritis Cartilage. 2013 Aug;21(8):1042-52. doi: 10.1016/j.joca.2013.05.002. Epub 2013 May 13.
- Konola VM, Parkkari J, Multanen J, Nikander R, Rantalainen T, Vesanto J, Pekkala S, Kalaja M, Ihalainen JK, Waller B, Munukka M, Sievanen H, Nevalainen M, Kautiainen H, Casula V, Paloneva J, Vasankari T, Peuna A, Saarakkala S, Nieminen MT, Heinonen A. Effects of a multicomponent exercise regimen on subchondral bone and cartilage in postmenopausal women with knee osteoarthritis: protocol for a randomized controlled trial. Trials. 2025 Jun 23;26(1):222. doi: 10.1186/s13063-025-08928-1.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21000057531
- 351483 (Other Grant/Funding Number: Academy of Finland)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Multicomponent exercise regimen
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeUnknownFrail Elderly Syndrome
-
Federal University of Rio Grande do SulRecruiting
-
Fundacion Miguel ServetCompletedCancer | Aging | Hospital Acquired Condition | DebilitySpain
-
Instituto Politécnico de BragançaCompleted
-
University of SalamancaNot yet recruitingExercise | Aging
-
Universitat Internacional de CatalunyaUnknownBone Diseases | Exercise | Osteoporosis | Osteoporosis, Postmenopausal
-
Fundacion Miguel ServetUniversidad Pública de Navarra; Complejo Hospitalario de NavarraCompletedFrailty | Disability Physical | Hospital Acquired ConditionSpain
-
Universidade Federal de Sao CarlosCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Completed
-
Hong Kong Baptist UniversityRecruitingDepressive SymptomsHong Kong
-
University of Beira InteriorEnrolling by invitationMild Cognitive Impairment (MCI) | Older PeoplePortugal